Daniel L. Flynn
Daniel L. Flynn founded Deciphera Pharmaceuticals, Inc. and Deciphera Pharmaceuticals LLC. Currently, Dr. Flynn holds the position of Chief Scientific Officer & Executive VP at Deciphera Pharmaceuticals, Inc. and Director & Chief Scientific Officer at Deciphera Pharmaceuticals LLC (a subsidiary of Deciphera Pharmaceuticals, Inc.).
In the past Daniel L. Flynn occupied the position of Director-Medicinal Chemistry at Amgen, Inc., Principal at Warner-Lambert Co., Senior Director-Chemistry at Millennium Pharmaceuticals, Inc., Director-Medicinal Chemistry at Monsanto Co., Principal at G.D. Searle & Co., Inc., Principal at Parke-Davis Pharmaceutical Research, Inc. and Chairman-Medicinal Chemistry Division at American Chemical Society.
Daniel L. Flynn received a doctorate and an undergraduate degree from the University of Kansas.
Transactions
| 01/17/2023 | 2,403 | Disposition at $21.24 per share. | 51,040 |
| 06/16/2022 | 1,768 | Disposition at $10.75 per share. | 19,006 |
| 02/16/2022 | 1,366 | Disposition at $9.05 per share. | 12,363 |
| 01/18/2022 | 20,500 | Award at $0 per share. | 0 |
| 12/15/2021 | 11,100 | Award at $0 per share. | 0 |
| 02/16/2021 | 11,100 | Award at $0 per share. | 0 |
| 02/16/2021 | 508 | Disposition at $48.87 per share. | 24,826 |
| 08/10/2020 | 9,029 | Derivative/Non-derivative trans. at $1.89 per share. | 17,064 |
| 07/22/2020 | 130,000 | Derivative/Non-derivative trans. at $1.89 per share. | 245,700 |
| 02/18/2020 | 7,040 | Award at $0 per share. | 0 |
| 01/16/2020 | 56,800 | Derivative/Non-derivative trans. at $6.13 per share. | 348,184 |
| 01/16/2020 | 10,106 | Derivative/Non-derivative trans. at $3.95 per share. | 39,918 |
| 12/12/2019 | 31,029 | Disposition at $60 per share. | 1,861,740 |
| 12/10/2019 | 93,930 | Disposition at $55 per share. | 5,166,150 |
| 12/10/2019 | 93,930 | Derivative/Non-derivative trans. at $1.89 per share. | 177,527 |
| 12/10/2019 | 28,822 | Disposition at $55 per share. | 1,585,210 |
| 12/10/2019 | 28,822 | Derivative/Non-derivative trans. at $1.89 per share. | 54,473 |
| 12/09/2019 | 30,175 | Disposition at $55 per share. | 1,659,625 |
| 12/09/2019 | 30,175 | Derivative/Non-derivative trans. at $1.89 per share. | 57,030 |
| 11/11/2019 | 143,185 | Disposition at $48.01 per share. | 6,874,312 |
| 11/11/2019 | 143,185 | Derivative/Non-derivative trans. at $1.89 per share. | 270,619 |
| 11/08/2019 | 9,742 | Disposition at $48 per share. | 467,616 |
| 11/08/2019 | 9,742 | Derivative/Non-derivative trans. at $1.89 per share. | 18,412 |
| 10/28/2019 | 29,820 | Disposition at $40 per share. | 1,192,800 |
| 10/28/2019 | 29,820 | Derivative/Non-derivative trans. at $1.89 per share. | 56,359 |
| 08/13/2019 | 25,000 | Disposition at $42.9 per share. | 1,072,500 |
| 08/13/2019 | 29,712 | Disposition at $41.33 per share. | 1,227,997 |
| 08/13/2019 | 93,395 | Disposition at $40.26 per share. | 3,760,083 |
| 08/13/2019 | 123,107 | Derivative/Non-derivative trans. at $1.89 per share. | 232,672 |
| 02/21/2019 | 24,500 | Derivative/Non-derivative trans. at $3.95 per share. | 96,775 |
| 01/16/2019 | 152,629 | Disposition at $26 per share. | 3,968,354 |
| 01/16/2019 | 152,629 | Derivative/Non-derivative trans. at $1.89 per share. | 288,468 |
| 01/11/2019 | 300 | Disposition at $26 per share. | 7,800 |
| 01/11/2019 | 300 | Derivative/Non-derivative trans. at $1.89 per share. | 567 |
| 03/23/2018 | 91,779 | Gift at $0 per share. | 0 |
| 03/23/2018 | 91,779 | Gift at $0 per share. | 0 |
